Revisiting the term neuroprotection in chronic and degenerative diseases

Revisiting the term neuroprotection in chronic and degenerative diseases

Author Orsini, Marco Google Scholar
Nascimento, Osvaldo J. M. Google Scholar
Matta, Andre P. C. Google Scholar
Melo Reis, Carlos Henrique Google Scholar
de Souza, Olivia Gameiro Google Scholar
Bastos, Victor Hugo Google Scholar
Moreira, Rayele Google Scholar
Ribeiro, Pedro Google Scholar
Fiorelli, Stenio Google Scholar
Novellino, Pietro Google Scholar
Pessoa, Bruno Google Scholar
Cunha, Mariana Google Scholar
Pupe, Camila Google Scholar
Morales, Pedro S. Google Scholar
Moreira Filho, Pedro F. Google Scholar
Trajano, Eduardo Lima Google Scholar
Oliveira, Acary Bulle Autor UNIFESP Google Scholar
Abstract Thanks to the development of several new researches, the lifetime presented a significant increase, even so, we still have many obstacles to overcome - among them, manage and get responses regarding neurodegenerative diseases. Where we are in the understanding of neuroprotection? Do we really have protective therapies for diseases considered degeneratives such as amyotrophic lateral sclerosis and its variants, Parkinson's disease, Alzheimer's disease and many others? Neuroprotection is defined by many researches as interactions and interventions that can slow down or even inhibit the progression of neuronal degeneration process. We make some considerations on this neuroprotective effect.
Keywords Neuroplasticity
Degenerative Diseases
Language English
Date 2016
Published in Neurology International. Pavia, v. 8, n. 1, p. UNSP 6311, 2016.
ISSN 2035-8385 (Sherpa/Romeo, impact factor)
Publisher Pagepress publ
Extent UNSP 6311
Access rights Open access Open Access
Type Article
Web of Science ID WOS:000378601600003

Show full item record


Name: WOS000378601600003.pdf
Size: 510.4Kb
Format: PDF
Open file

This item appears in the following Collection(s)




My Account